CASP9 and colorectal carcinoma: Mutation of this protein prevents β-catenin degradation, thereby activating the Wnt pathway, which inhibits enzymes involved in apoptosis, such as caspase 3, caspase 9, and cytochrome c, allowing malignant cells to evade apoptosis and leading to CRC progression [52].